Citigroup Maintains Buy on CME Gr, Raises Price Target to $240
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Christopher Allen maintains a Buy rating on CME Group (NASDAQ:CME) and raises the price target from $215 to $240.
October 12, 2023 | 2:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup maintains a Buy rating on CME Group and raises the price target from $215 to $240, which could lead to a positive market reaction.
The raised price target by Citigroup indicates a positive outlook for CME Group. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100